Kim P. Kamdar's Net Worth

-$274 Thousand

Who is Kim P. Kamdar?

Kim P. Kamdar does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MARINUS PHARMACEUTICALS INC, GLAUKOS Corp, Singular Genomics Systems, Inc., Aldeyra Therapeutics, Inc., Syndax Pharmaceuticals Inc, Esperion Therapeutics, Inc., Clovis Oncology, Inc., OBALON THERAPEUTICS INC, Evoke Pharma Inc, Bionano Genomics, Inc., aTYR PHARMA INC, Evofem Biosciences, Inc., Durata Therapeutics, Inc., SERA PROGNOSTICS, INC., ZOGENIX, INC., Regado Biosciences Inc, Orexigen Therapeutics, Inc., ACHILLION PHARMACEUTICALS INC, Celator Pharmaceuticals Inc, CADENCE PHARMACEUTICALS INC, and Ocera Therapeutics, Inc..

SEC CIK

Kim P. Kamdar's CIK is 0001535065

Past Insider Trading and Trends

2016 was Kim P. Kamdar's most active year for acquiring shares with 6 total transactions. Kim P. Kamdar's most active month to acquire stocks was the month of May. 2023 was Kim P. Kamdar's most active year for disposing of shares, totalling 1 transactions. Kim P. Kamdar's most active month to dispose stocks was the month of November. 2016 saw Kim P. Kamdar paying a total of $201,000.00 for 121,333 shares, this is the most they've acquired in one year. In 2023 Kim P. Kamdar cashed out on 10 shares for a total of $6.21, their largest year based on trade value.